Full text is available at the source.
Abstract
IBS-C patients often exhibit dysbiosis, characterized by reduced beneficial bacteria and increased inflammatory microbes.
- Dysbiosis in IBS-C is associated with reduced production of short-chain fatty acids.
- Altered gut microbiota may impair gut motility and serotonin signaling, affecting bowel function.
- Increased intestinal permeability and inflammation are linked to worsened pain and gastrointestinal dysfunction.
- Changes in gut motility and serotonin metabolism contribute to the overall symptoms of IBS-C.
- Inconsistencies in existing research emphasize the need for standardized methods in future studies.
Simplified